« Purchase of “renewal” for my 12-year-old girl who is asthmatic since she was 4 years old. For some time, she has been sleeping with two pillows, one of which was not wrapped, and I have noticed a worsening of sneezing. So I try to wrap this 2nd pillow to limit its reaction to mites. Stay tuned…
PS: The rest of the bedding is protected for a long time and I am very satisfied with ProtecSom products. »
The year 2017 has been fruitful for CombiHaler®, our spacer for mechanical ventilation circuits. Several scientific publications published this year reveal the eagerness of the scientific community to work with our spacer for mechanical ventilation circuits, developed jointly with “l’Université de Tours”.
By studying the feasibility to connect CombiHaler® on different types of circuits (high flow nasal canula and single-limb non-invasive ventilation), the first 2 articles (Madney, 2017 and Harb, 2017) have opened up new prospects for the use of CombiHaler®.
The last article published in October (Rodriguez, 2017) presents encouraging results for the treatment of pulmonary infections that requires high antibiotics concentrations. By increasing the dose delivered directly de the patients’ lungs, the dose of antibiotics to the site of infection is increased, systemic side effects are reduced, and antibiotic resistance accrual is potentially limited.
This enthusiasm from the scientific community hints at a very bright future for CombiHaler®and its evolutions of our range of spacers for mechanical ventilation.
The Laboratoire ProtecSom-OptimHal is currently present at MEDICA Tradefair 2017, World Forum for Medicine, in Düsseldorf (Germany) until November 16th, 2017.
In 2016, this international event attracted more than 5100 exhibitors from 70 different countries and reveals all the facets of medical technology and medical products world market.
Find us at the French pavilion in Hall 17 on C23 booth to discover our interfaces of inhalation dedicated to respiratory diseases as the TipsHaler®valved holding chamber or the OrHal®partitioned mask… but also our protective devices for the allergic patients as the Texaal®dust mite covers.
Dedicated to innovation since 1970, the Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation that improves the state of human health.
The most innovative Franco-American collaborations have been awarded during the Prix Galien – MedstartUp ceremony on Thursday 26 October in New-York.
A rigorous selection dedicated to global excellence
Following a drastic selection, only 11 out of 50 companies were nominated for the innovative aspect of their healthcare solutions.
ProtecSom-OptimHal laboratory was rewarded for :
« The Best Collaboration with academia Leading to a Breakthrough Solution »
A partnership with the Virginia Commonwealth University, Professor Bruce Rubin and PharmaSystems Inc.
« The Best Use of Patient Engagement Technologies »
A partnership with L’Association Pulmonaire in Québec and PharmaSystems Inc.
This historic victory is a great achievement for ProtecSom-OptimHal, thus proving recognition for its efforts in terms of innovation for healthcare.
A word from the Scientific Director
« I am very proud of these two successes and I congratulate our research teams for the quality of their work that has enabled these partnerships. This is an important asset for our company on American soil where we find ourselves partners with Professor Bruce Rubin whose life is dedicated to the health of children. » – Thierry Porée
From 12 till 14 October, the Convention Center of Quebec welcomes the 2me Biennale de l’Espace Francophone de Pneumologie.
The laboratoire ProtecSom-OptimHal will be present during this Congress gathering of several healthcare professionals and healthcare researchers of more than 25 French-speaking countries.
Theme : The medicine of precision
The theme of this 2nd edition “The medicine of precision” proposes to the patient a personalized treatment and adapted to the characteristics of the patient and its pathology, by taking into account its physical and sociocultural environment.
This initiative has for objective to guarantee a sustainable cooperation with the French-speaking countries, to ensure the sharing of knowledge and experiences, and finally to strengthen the development of collaborative research projects in pneumology.
Valved holding chamber TipsHaler® optimized for lung deposition of inhaled corticosteroids
In order to provide an actual progress to patients as well as caregivers, this initiative represents an opportunity for ProtecSom-OptimHal to introduce the valved holding chamber, TipsHaler®.
TipsHaler® is an innovant medical device which allows to limit upper airway depositions and to promote drug deposition in the deep lung, where the medicine is needed.
Mask OrHal® avoids nasal inhalation
Partitioned pediatric mask OrHal® will also be presented, which prevents from medicine deposit in the nose, and allows more deposition of drugs deeper in the lung during inspiration.
Dust mite bedding covers : a full fledged medical device
As well as our valved holding chambers, we will also show dust mite bedding covers as Texaal® Coton and Texaal® Polyester as well as Noxaalon® and Noxaalon® Bamboo ProtecSom-OptimHal covers design, manufacturing and control process is ISO 13485 (standard of fabrication for medical devices). It protects patients from dust mite allergens.
An abstract from a multicenter, randomized, double-blind, placebo-controlled clinical trial was selected by the Francophone Congress of Allergology scientific committee to be exhibited at its 12th edition from April 26 to 28, 2017.
This study highlights the role of Texaal® anti-dust mite covers in the evolution of symptoms of allergic rhinitis.
The poster will be presented on Thursday 27th at 10 am and will be available during the congress (All-12 – Rubric: Allergens).
Loading Comments...
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.Ok